The new plant at Evonik’s Tippecanoe site in Lafayette, Indiana, will broadly position the Group for future growth in novel mRNA-based therapies beyond COVID-19 vaccines and strengthen its leading role as a strategic partner for innovative pharmaceutical companies worldwide. ... MORE
Learn more about the unique emulsion-based process and how it helps overcome the limitations of your poorly soluble API ... MORE
The large-scale production of PhytoChol® in Hanau, Germany, will meet an increased market demand for cholesterol. ... MORE
The award by Life Science Leader and Outsourced Pharma highlights excellence in pharmaceutical contract manufacturing across six categories ... MORE
Highest flexibility for 3D printing of personalized, implantable medical devices ... MORE
Evonik’s next generation recombinant collagen, VECOLLAN®, is a unique, non-animal derived biomaterial platform. This highly pure collagen is manufactured via fermentation and can be used in a wide range of medical applications. Join our webinar on July 13 to learn more about this fascinating biomaterial. ... MORE
Unlock the Potential of Your API with our oral excipients ... MORE
The highest load omega-3 powder ingredient in its class for dietary supplements ... MORE
Biodegradable material solutions to enhance the safety, biocompatibility and performance of medical implants ... MORE
As a CDMO expert we provide modern, established sites for LNP manufacturing and filling, as well as process technologies for CGMP manufacturing ... MORE
Evonik is a preferred CMO Partner for APIs, HPAPIs, intermediates and products made by fermentation ... MORE
Dietary supplements that leverage our advanced health ingredients and oral dosage form expertise ... MORE
We are a Market Leader for Parenteral Excipients ... MORE
Our broad and flexible portfolio of drug delivery systems enables you to to optimize drug performance with superior targeting outcomes ... MORE
Evonik is one of the world’s leading CDMO for complex parenteral drug products ... MORE
Proprietary surface modification technology to improve medical device safety and functionality ... MORE
EUDRACAP™ leverages the functional versatility and safety of EUDRAGIT® to solve key challenges in oral drug delivery ... MORE
Follow Evonik Health Care on LinkedIn to keep updated about our products, webinars and news ... MORE
Visit onCare to access all product and regulatory information, 24/7 ... MORE
The new plant will broadly position the Group for future growth in mRNA-based therapies and strengthen its leading role as a strategic partner for pharmaceutical companies worldwide. ... MORE
Evonik is transforming its Health Care business to maximize customer centricity and market focus. Effective April 1, 2022, the company will streamline its operations into three new product lines: Drug Delivery & Product, Drug Substance, and Health Solutions. ... MORE
Effective April 1, 2022, Evonik’s Health Care business line will be implementing a price increase of up to 45 percent across the portfolio of products, technologies, and services for pharmaceutical, nutraceutical and medical device markets. ... MORE
EUDRATEC® SoluFlow, a new microparticle technology for solubility enhancement of APIs, overcomes solubility hurdles that cannot be resolved by existing manufacturing technologies. ... MORE
Plant-derived cholesterol is one of the most critical components for the manufacture of mRNA vaccines and gene therapies. The large-scale production of PhytoChol® in Hanau, Germany, will meet an increased market demand for cholesterol. ... MORE
Organized by the publications Life Science Leader and Outsourced Pharma, the CMO Leadership Awards highlight excellence in pharmaceutical contract manufacturing across six categories. ... MORE
Each year, we put up a program of online and in-person workshops, deep-diving into design, handling and processing of our products as well as latest challenges, solutions and trends in the industry. ... MORE
Subscribe to the Health Care Bulletin to stay up-to-date on industry trends, new Evonik products and services, scientific updates and upcoming events and webinars. ... MORE
